These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Differential distribution of fibroblast growth factor receptors (FGFRs) on foveal cones: FGFR-4 is an early marker of cone photoreceptors. Cornish EE; Natoli RC; Hendrickson A; Provis JM Mol Vis; 2004 Jan; 10():1-14. PubMed ID: 14737068 [TBL] [Abstract][Full Text] [Related]
4. Localisation and differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal and atherosclerotic human arteries. Hughes SE Cardiovasc Res; 1996 Sep; 32(3):557-69. PubMed ID: 8881516 [TBL] [Abstract][Full Text] [Related]
5. FGF receptors: cancer biology and therapeutics. Katoh M; Nakagama H Med Res Rev; 2014 Mar; 34(2):280-300. PubMed ID: 23696246 [TBL] [Abstract][Full Text] [Related]
7. [From gene to disease; craniosynostosis syndromes due to FGFR2-mutation]. van Ravenswaaij-Arts CM; van den Ouweland AM; Hoogeboom AJ; Herbergs J; Pals G Ned Tijdschr Geneeskd; 2002 Jan; 146(2):63-6. PubMed ID: 11820058 [TBL] [Abstract][Full Text] [Related]
8. Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4. Hart KC; Robertson SC; Kanemitsu MY; Meyer AN; Tynan JA; Donoghue DJ Oncogene; 2000 Jul; 19(29):3309-20. PubMed ID: 10918587 [TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implications. Helsten T; Schwaederle M; Kurzrock R Cancer Metastasis Rev; 2015 Sep; 34(3):479-96. PubMed ID: 26224133 [TBL] [Abstract][Full Text] [Related]
11. Proline to arginine mutations in FGF receptors 1 and 3 result in Pfeiffer and Muenke craniosynostosis syndromes through enhancement of FGF binding affinity. Ibrahimi OA; Zhang F; Eliseenkova AV; Linhardt RJ; Mohammadi M Hum Mol Genet; 2004 Jan; 13(1):69-78. PubMed ID: 14613973 [TBL] [Abstract][Full Text] [Related]
12. The role of fibroblast growth factor receptor (FGFR) protein-tyrosine kinase inhibitors in the treatment of cancers including those of the urinary bladder. Roskoski R Pharmacol Res; 2020 Jan; 151():104567. PubMed ID: 31770593 [TBL] [Abstract][Full Text] [Related]
13. Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers. Jang JH; Shin KH; Park JG Cancer Res; 2001 May; 61(9):3541-3. PubMed ID: 11325814 [TBL] [Abstract][Full Text] [Related]
14. Common and specific determinants for fibroblast growth factors in the ectodomain of the receptor kinase complex. Wang F; Lu W; McKeehan K; Mohamedali K; Gabriel JL; Kan M; McKeehan WL Biochemistry; 1999 Jan; 38(1):160-71. PubMed ID: 9890894 [TBL] [Abstract][Full Text] [Related]